Genomics, Cancer Care and Advocacy
by S.F. Terry, K. Zeitz, M.A. Majumder, P.F. Terry
Publisher: Genetic Alliance 2006
Number of pages: 29
In the past several decades, oncologists and cancer researchers have come to recognize the importance of the role of advocacy organizations in cancer research and treatment. With genomics poised to become a major force in cancer care, advocacy organizations have an important role to play in traditional areas of concern such as patient education about new genomic technologies.
Home page url
Download or read it online for free here:
- National Institute for Health and Care Excellence
This guideline aims to facilitate standardisation of practice in treating non-Hodgkin's lymphoma. But because of the rapid development of new therapies as a result of improved understanding of the disease, continual re-evaluation will be essential.
- National Collaborating Centre for Cancer
These guidelines have been developed to help all those involved in the management of advanced breast cancer. The authors have tried to concentrate on those areas where it was felt uncertainty or practice variation currently exists.
- Royal College of General Practitioners
The guideline covers twelve groups of cancers: lung, upper gastrointestinal cancers, lower gastrointestinal cancers, breast cancer, gynaecological cancers, urological cancers, haematological cancers, skin cancers, head and neck cancers, etc.
- World Health Organization
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. It outlines the complementary strategies, and highlights the need for collaboration across programmes, organizations and partners.